Switzerland1 robot tracked

Distalmotion

Distalmotion makes Dexter, which is at stage 5 of 5: regulator-cleared or mass market.

Website: distalmotion.com
Based in: Switzerland
Latest milestone: 16 June 2026

01Robots

What Distalmotion makes

Each robot's stage is worked out from its dated, sourced milestones by the same published rules, whoever the maker is.

DexterMedical · Compact keyhole-surgery robotStage 5 of 5 · Regulator-cleared or mass marketDexter is a small, movable surgical robot for keyhole (laparoscopic) surgery, built to fit outpatient surgery centers. It works with other companies' cameras and tools and uses wristed, single-use instruments.In use in Europe and, since late 2024, at US hospitals and outpatient centers such as UC San Diego Health and AdventHealth.The full record

02Track record

Every dated event

16 June 2026Regulator
The FDA cleared Dexter for more gynecology operations, including pelvic-organ prolapse repair and endometriosis surgery: its fourth US clearance.
MassDevice, 16 June 2026Company-reported
18 Nov 2025Milestone
Distalmotion raised $150 million, led by Revival Healthcare Capital, to grow US sales. In January 2026 Johnson & Johnson's venture arm also invested an undisclosed amount.
MassDevice, 18 Nov 2025Company-reported
1 Oct 2025Regulator
The FDA cleared Dexter for hysterectomy (removal of the womb) through the 510(k) route.
MassDevice, 1 Oct 2025Company-reported
26 June 2025Milestone
AdventHealth, which runs 50 hospitals in nine states, bought several Dexter robots: the company's first multi-robot sale in the US.
MassDevice, 26 June 2025Company-reported
28 May 2025Regulator
The FDA cleared Dexter for gallbladder removal through the 510(k) route.
MassDevice, 28 May 2025Company-reported
26 Nov 2024Milestone
Surgeons at UC San Diego Health did the first two US outpatient operations with Dexter, both hernia repairs.
MassDevice, 3 Dec 2024Company-reported
25 Oct 2024Regulator
The FDA cleared Dexter through the De Novo route (DEN230084) for groin (inguinal) hernia repair in adults. More than 1,300 patients had already been treated with it in Europe.
MassDevice, 28 Oct 2024 (FDA record DEN230084)

03Money

How it's funded

Latest funding round we could confirm: Distalmotion took a strategic investment of an undisclosed amount from Johnson & Johnson's venture arm, after closing a $150 million Series G round in 2025. BioAlps, 13 Jan 2026 Company-reported

All robot stocks, funding and suppliers